Design and discovery of neuropeptide Y1 receptor antagonists

Drug Discovery Today

Volumn 2, Issue 1, 1997, Pages 19-24

  Wright, J ^a  

^a PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARPROMIDINE; BENEXTRAMINE; CC 2137; GR 231118; N [1 [4 [[[[4 [(DIMETHYLAMINO)METHYL]CYCLOHEXYL]METHYL]AMINO]IMINOMETHYL]BENZYL] 2 OXO 2 (1 PYRROLIDINYL)ETHYL] ALPHA [(2 NAPHTHALENYLSULFONYL)AMINO]BENZENEPROPANAMIDE; NALPHA (DIPHENYLACETYL) N (4 HYDROXYBENZYL) DEXTRO ARGININAMIDE; NEUROPEPTIDE RECEPTOR; NEUROPEPTIDE Y; NEUROPEPTIDE Y DERIVATIVE; NEUROPEPTIDE Y RECEPTOR; NEUROPEPTIDE Y RECEPTOR ANTAGONIST; NEUROPEPTIDE Y1 RECEPTOR; PANCREAS POLYPEPTIDE; PD 160170; RECEPTOR SUBTYPE; SR 120107A; UNCLASSIFIED DRUG;

CENTRAL NERVOUS SYSTEM; DRUG ACTIVITY; DRUG DESIGN; DRUG RECEPTOR BINDING; HUMAN; NONHUMAN; REVIEW;

EID: 0030873083     PISSN: 13596446     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1359-6446(96)10049-0     Document Type: Review

References (67)

1. Tatemoto K. Proc. Natl. Acad. Sci. U. S. A. 79 1982 5485 5489
2. Tatemoto K. Carlquist M. Mutt V. Nature 296 1982 659 661
3. Cowley D.J. Eur. J. Biochem. 205 1992 1099 1106
4. Darbon H. Eur. J. Biochem. 209 1992 765 771
5. Saudek V. Pelton J.T. Biochemistry 29 1990 4509 4515
6. Schwartz T.W. Ann. New York Acad. Sci. 611 1990 35 47
7. Allen J.M. Ann. New York Acad. Sci. 611 1990 86 98
8. Larhammar D. Blomqvist A.G. Soderberg C. Comp. Biochem. Physiol. 106C 1993 743 752
9. Larhammar D. Regul Pept. 62 1996 1 11
10. Grundemar L. Hkanson R. Trends Pharmacol. Sci. 15 1994 153 159
11. Dhanoa D.S. Exp. Opin. Ther. Patents 5 1995 391 396
12. Wettstein J.G. Earley B. Junien J.L. Pharmacol. Ther. 65 1995 397 414
13. Beck-Sickinger A.G. Jung G. Biopolymers 37 1995 123 142
14. Michel M.C. Trends Pharmacol. Sci. 12 1991 389 394
15. Wahlestedt C. Reis DJ. Annu. Rev. Pharmacol. Toxicol. 33 1993 309 352
16. Herzog H. Proc. Natl. Acad. Sci. U. S. A. 89 1992 5794 5798
17. Gerald C. J. Biol. Chem. 270 1995 26758 26761
18. Gehlert D.R. Mol. Pharmacol. 49 1996 224 228
19. Bard J.A. J. Biol Chem. 270 1995 26762 26765
20. Gerald C. Nature 382 1996 168 171
21. Weinberg D.H. Biol Chem. 271 1996 16435 16438
22. Gregor P. FEBS Lett. 381 1996 58 62
23. Edvinsson L. Neuropeptides 17 1990 99 105
24. Sun X. J. Pharm. Pharmacol. 48 1996 77 84
25. Sun X. Eur. J. Pharmacol. 204 1991 281 286
26. Feth F. Life Sci. 52 1993 1835 1844
27. Heilig M. Eur. J. Pharmacol. 204 1991 27 32
28. Tatemoto K. Proc. Natl. Acad. Sci. U. S. A. 89 1992 1174 1178
29. Leibowitz S.F. NeuroReport 3 1992 1023 1026
30. Beck B. Neurosci. Lett. 181 1994 126 128
31. Palea S. Br. J. Pharmacol. 116 1995 2401 2406
32. Wieland H.A. J. Pharmacol. Exp. Ther. 275 1995 143 149
33. Doughty M.B. Eur. J. Pharmacol. 185 1990 113 114
34. Tessel R.E. J. Pharmacol. Exp. Ther. 265 1993 172 177
35. Chaurasia C. J. Med. Chem. 37 1994 2242 2248
36. Palea S. Br. J. Pharmacol. 115 1995 3 10
37. Dhanoa D.S. Data presented at ACS National Meeting 20–24 August, Chicago 1995
38. Knieps S. Bioorg. Med. Chem. Lett. 5 1995 2065 2070
39. Balasubramaniam A. J. Med. Chem. 37 6 1994 811 815
40. Balasubramaniam A. J. Biol. Chem. 265 1990 14724 14727
41. Beck-Sickinger A.G. Jung G. Biopolymers 37 1995 123 142
42. Kirby D.A. J. Med. Chem. 36 1993 3802 3808
43. Beck A. FEBS Lett. 1 1989 119 122
44. Balasubramaniam A. J. Med. Chem. 39 1996 1142 1147
45. Balasubramaniam A. J. Med. Chem. 39 1996 811 813
46. Heyer D. Data presented at ACS National Meeting March, New Orleans 1996
47. Daniels A.J. Proc. Natl. Acad. Sci. U. S. A. 92 1995 9067 9071
48. Hegde S.S. J. Pharmacol. Exp. Ther. 275 1995 1261 1266
49. Lew M.J. Br. J. Pharmacol. 117 1996 1768 1772
50. Ihara M. Physiologist 38 1995 A251
51. Kanatani A. Endocrinology 137 1996 3177 3182
52. Rudolf K. Eur. J. Pharmacol. 271 1994 R11 R13
53. Sautel M. Mol. Pharmacol. 50 1996 285 292
54. Doods H.N. Regul. Pept. 65 1996 71 77
55. Wieland HA J. Pharmacol. Exp. Ther. 275 1995 143 149
56. Abounader R. Br. J. Pharmacol. 116 1995 2245 2250
57. Nilsson T. Neurosci. Lett. 204 1996 145 148
58. Serradeil-Le Gal C. FEBS Lett. 362 1995 192 196
59. Serradeil-Le Gal C. Soc. Neurosci. Abstr. 376 1994 14
60. Malmström R.E. Modin A. Lundberg J.M. Eur. J. Pharmacol. 305 1996 145 154
61. Malmström R.E. Lundberg J.M. Acta Physiol. Scand. 155 1995 329 330
62. Wright J.L. Bioorg. Med. Chem. Lett. 6 1996 1809 1814
63. Bruns, R. et al. (1996) WO 96/12489, 96/12490
64. Bruns, R. et al. (1996) US Patent 5,504,094
65. Peterson, J.M. et al. (1996) WO 96/14307
66. Erickson J.C. Nature 381 1996 415 418
67. Colmers W.F. Bleakman D. Trends Neurosci. 17 1994 373 379